This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Daniela Della Ducata: Innovator in Antibody Research
Introduction
Daniela Della Ducata is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibody therapies. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Della Ducata holds a patent for IL-17A antibodies. This patent includes Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using these innovations. This patent represents a significant advancement in therapeutic options for various diseases.
Career Highlights
Currently, Daniela Della Ducata is employed at Janssen Biotech, Inc., where she continues to push the boundaries of scientific research. Her dedication to innovation has positioned her as a key player in the biotechnology sector.
Collaborations
Throughout her career, Della Ducata has collaborated with notable colleagues, including Juan C Almagro and Merle Elloso. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Daniela Della Ducata exemplifies the spirit of innovation in the biotechnology field. Her contributions, particularly in antibody research, are paving the way for new therapeutic approaches. Her work continues to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile